[Profiles of serological markers of HBV-infection in acute hepatitis B]. 1996

N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
Clinic Hospital of Infectious Diseases N3, Moscow.

The authors demonstrate that severe and fulminant forms of acute hepatitis B (AHB) are associated with low concentrations of HBsAg and anti HBs in peripheral blood. In the majority of cyclic AHB cases HBeAg is registered in the serum for 2-3 weeks, whereas in more severe course of AHB its indication is shorter, with occasional occurrence of serological window. The more severe and longer was AHB course the lower was concentration of HBsAg in peripheral blood. The assessment of the complete profile of serological markers of HBV infection and HBsAg concentration in the serum in the course of the disease will promote more effective diagnosis of the disease pattern and outcome.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
March 1988, Irish journal of medical science,
N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
January 1980, Clinics in gastroenterology,
N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
April 2013, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
April 1985, The New Zealand medical journal,
N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
July 1993, Journal of hepatology,
N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
April 2003, The American journal of gastroenterology,
N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
October 1978, Scandinavian journal of clinical and laboratory investigation,
N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
May 2020, European journal of haematology,
N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
January 1998, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
N D Nikiforov, and B I Sanin, and G S Nikiforova, and E S Saiapina, and L V Novikova, and I A Il'inskii, and A F Popov
December 1981, American journal of clinical pathology,
Copied contents to your clipboard!